Benchstrength Partners — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Altis provides independent, IC-grade investment diligence and market research on private companies from Seed to Series D+, working outside-in without access to management or data rooms.
AI & Machine LearningData & InfrastructureFintech
Co-investorsPrimary Venture PartnersDebiopharm Innovation FundGalapagos Capital
Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesToronto, CA
Felix Baldauf-Lenschen(Founder & CEO)inJohn(CTO)
Co-investorsCreative Destruction Lab (CDL)Debiopharm Innovation FundFusionOrbiMed
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



